What COVID-19 concept stocks are there?

1, Yongtai Technology: The current market value is 47.939 billion. On September 7th, Yongtai Technology opened at 50. 15 yuan today and closed at 15. The stock rose 10% to 54.69 yuan. The company sought to cooperate with the procurement of future intermediates of Gilead drug Remdesivir, and the first confirmed case in COVID-19, USA, was rapidly relieved after receiving Remdesivir treatment. The interactive platform of the company replied that it participated in the production of drugs and intermediates related to Wuhan COVID-19.

2. Huachang Chemical: On September 7, Huachang Chemical closed at 15, and its share price rose by 6.38% to 14.34 yuan; Within five days, the stock price rose by 6.69%, and the market value was1365.7 billion yuan. In February 2000, Nanjing Shihe Gene and Practical Medicine invested by Suzhou Ruihua Investment Partnership (the company holds 10% of the fund share) successfully developed the COVID-19 nucleic acid detection kit.

3. Wanbang: The current market value is 6.627 billion. On September 7th, Wanbang opened 10.6 1 yuan. As of 15, the stock rose by 1.23% to 10.72 yuan. The company has chlorphenamine maleate tablets; Researchers in Utah are studying the therapeutic effect of nasal spray containing antihistamines on cell culture infected with COVID-19 virus. The preliminary results of this new in vitro study showed that chlorphenamine maleate (CPM) combined with nasal spray can reduce the incidence of infection.

4. Sinopharm Modern: On September 7th, it was reported to 9.9 yuan today. As of 15, the stock rose 1. 1% to 10.09 yuan. The current market value is 654.38+00.362 billion. The holding subsidiary Hyundai Hasen produces chlorphenamine maleate. According to a preliminary study in Utah, USA, the drug has therapeutic effect on infected COVID-19 cells.

5. Wanfu Bio: In February, 2000, it was revealed that the antibody detection kit (colloidal gold method) of novel coronavirus (20 19-nCoV) passed the emergency examination and approval of the State Administration of Medical Supplies, officially obtained the medical device registration certificate, and became the first batch of on-site rapid detection reagents for COVID-19 antibodies officially approved for listing.

6. Shelley: The company was listed as the second batch of key enterprises for epidemic prevention and control in COVID-19 by the Ministry of Industry and Information Technology and the first batch of key enterprises for epidemic prevention and control materials in Foshan by the Foshan Municipal Bureau of Industry and Information Technology; The company has been researching and producing ultraviolet germicidal lamps for nearly 20 years, and participated in drafting the national standard of ultraviolet germicidal lamps. The company has many inventions, utility models and design patents in the field of ultraviolet germicidal lamps, and its ultraviolet germicidal lamps have a high reputation at home and abroad and in the industry.

7. essence pharmaceutical: On February 20th, it was revealed that the company had raw materials and was organizing the production of chloroquine phosphate. The deputy director of the Biological Center of the Ministry of Science and Technology said that chloroquine phosphate is obviously effective in treating COVID-19.

8. Mingde Biology: The company's measuring instruments include immunochromatography QMT8000, whole blood chemiluminescence CF 10, blood gas PT 1000 and ST2000. Except ST2000, the company's instruments are all matched with the company's reagents. On February 20th, it was disclosed that the novel coronavirus nucleic acid detection reagent being registered can be applied to general fluorescent PCR instruments in the market. In April, 2000, COVID-19 20 19-nCoV nucleic acid detection kit (fluorescence PCR method) was selected as the centralized procurement project of related detection reagents in COVID-19, Hubei.